Boston, MA, United States of America

Matthew Stirling

USPTO Granted Patents = 7 


 

Average Co-Inventor Count = 6.2

ph-index = 3

Forward Citations = 31(Granted Patents)


Location History:

  • Randolph, MA (US) (2014 - 2017)
  • Boston, MA (US) (2008 - 2020)

Company Filing History:


Years Active: 2008-2020

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Matthew Stirling: Innovating in Cancer Treatment

Introduction

Matthew Stirling is a distinguished inventor based in Boston, MA, recognized for his significant contributions to the field of medicine with a focus on cancer treatment. With a total of seven patents to his name, his inventive work stands out in the world of pharmaceutical innovation.

Latest Patents

One of Matthew's latest patents is titled "Process for the synthesis of E1 activating enzyme inhibitors." This invention details processes and synthetic intermediates for creating 4-substituted sulfamates, which serve as E1 activating enzyme inhibitors. These compounds are especially beneficial for addressing disorders related to cell proliferation, such as cancer.

Another notable patent he holds is for "Inhibitors of NEDD8-activating enzyme." This patent discloses various chemical entities that inhibit the NEDD8-activating enzyme (NAE). It also covers methods for using these compounds to treat cancer and other related disorders.

Career Highlights

Matthew Stirling has made a significant impact while working at Millennium Pharmaceuticals Limited, a leading company in biopharmaceutical innovation. His focus on developing compounds that target specific enzymes has paved the way for potential breakthroughs in cancer therapy. His dedication to research and development in this field has made him a key player in pharmaceutical innovation.

Collaborations

Throughout his career, Matthew has collaborated with notable coworkers, including Ian G. Armitage and Eric L. Elliott. These partnerships have likely enhanced the breadth of his research and contributed to the successful development of his patented inventions.

Conclusion

In summary, Matthew Stirling exemplifies the spirit of innovation in the pharmaceutical industry. His patents, particularly in the realm of cancer treatment, highlight the critical role inventors play in advancing medical science and improving patient outcomes. As he continues to work with his talented team at Millennium Pharmaceuticals Limited, the potential for future breakthroughs in cancer treatment remains promising.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…